Compound ID | 2098
Synonym(s): Seromycin | orientomycin | oxamycin | tisomycin
Class: Isoxazoline
| Spectrum of activity: | Gram-positive |
| Details of activity: | Interferes with bacterial cell wall synthesis by competitively inhibiting two enzymes, L-alanine racemase and D-alanine:D-alanine ligase, thereby impairing peptidoglycan formation |
| Description: | Natural compound produced by Streptomyces. Used in the treatment of drug resistant tuberculosis; off-patent |
| Year first mentioned: | 1955 |
| Highest developmental phase: | Approved by FDA in 1964 |
| Development status: | Approved |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6234 |
| Guide to Pharmacology: | D-cycloserine |
| Citations: |
|